Patricia Lowrimore is a Psychiatry physician. OpenAlex indexes 5 publications with 242 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
855 Montgomery St
Fort Worth, TX 761072553
Telephone
817-702-4781Registry record last updated 5 May 2016.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Pharmaceuticals, IncProgram year20241 payment
- IDORSIA PHARMACEUTICALS US INCProgram year20241 payment
- IDORSIA PHARMACEUTICALS US INCProgram year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
85%SSRI29.4%Escitalopram Oxalate53%Sertraline Hcl21%Trazodone Hcl15%Fluoxetine Hcl11%Part D<11 patientsBenzodiazepine19%Lorazepam56%Clonazepam31%Alprazolam13%Part D<11 patients+ 5 more classes in this area
Cardiovascular
15%Central alpha-2 Adrenergic Agonist15%Clonidine Hcl72%Clonidine Hcl Er28%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CAG nucleotide repeat profiles in persons with schizophrenia or schizoaffective disorders with and without tardive dyskinesia: Pilot study
American Journal of Medical Genetics Part B Neuropsychiatric Genetics
2004 - Depression of Thalamic Metabolism by Lorazepam Is Associated with Sleepiness
Neuropsychopharmacology
1995 - The effect of lithium on the thrombin-induced 5-hydroxytryptamine release of human platelets in controls and subjects with affective disorders: A preliminary report
Asia Pacific journal of pharmacology
1989 - Ethanol enhances GABA-induced 36Cl-influx in primary spinal cord cultured neurons
Brain Research Bulletin
1986
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”